Global Health Limited — Investor Meet, 16-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Global Health Limited has announced a board meeting to approve the financial results for the quarter and half-year. FY2025 revenue grew 13% YoY to INR 3,771.4 Cr, driven by higher patient volumes. EBITDA rose 9.4% to INR 956.2 Cr (25.4% margin), while PAT was INR 481.3 Cr (12.8% margin), affected by a one-time merger cost of INR 49.9 Cr. Occupied bed days increased 10% with 219 new beds added. Expansion projects in key cities support plans to add ~3,000 beds over five years. Management focuses on clinical excellence, talent, and digital innovation to sustain growth.